voiding and UUI, respectively. There were 201 (11.5%) in the 0 wet/ happy 0 group (96 RP; 64 TO; 41 ARF). Postoperative SUI status was: 139 (69%) improved, 13 (6%) de novo, and 9 (4%) worse. Additional surgeries during the FU period were: 6% prolapse repair, 3% bulking, 2% repeat sling, 2% sling revision, and 1% sling incision. In 62 women having sling only, 89% had SUI improvement. Concomitant surgery inversely correlated with satisfaction.
INTRODUCTION AND OBJECTIVES: Chemokine (C-C motif) ligand 7(CCL7) is one of key factors homing stem cell to rescue injured urethra and related pudendal nerve for maintaining urinary continence, which increases in significance immediately after simulated birth injury. To explore if serious stress urinary incontinence (SUI) after birth injury has low CCL7 responsive expression at the local injury of urethra.
METHODS: 437 SUI patients preparing for sling procedure enrolled in the study for testing CCL7 expression via collection the blood sample from systematic vein (baseline expression) and local incision (responsive expression), and for inquiry a history if having SUI at last vaginal delivery. 411 individuals successively completed a simplified urinary incontinence inquiry to their last vaginal deliveries. 380 individual blood samples were effectively collected and tested. 352 SUI patients with both above data were analyzed and then assigned to 4 groups according to postpartum no SUI, mild SUI (<1/ week), severe SUI (every day), and moderate SUI (between mild and severe).
RESULTS: There were no significant differences at baseline expression of CCL7 between 4 groups. Compared to postpartum no SUI, the responsive expression of CCL7 was significantly low in the group of postpartum severe SUI (p<0.05). When CCL7 responsive expression standardized to the baseline expression, both groups of severe SUI (p<0.05) and moderate SUI (p<0.05) have lower CCL7 expression than group of postpartum no SUI.
CONCLUSIONS: The study demonstrated low local CCL7 responsive expression during sling procedure associated with postpartum SUI. CCL7 could become a biomarker indicating the risk of postpartum SUI. Delivery CCL7 might be an effective way to improve urinary continence immediately after birth injury.
Source of Funding: NSF China 81670695; China America Promotion Society for Medical Doctors (CAPs MD)
MP40-09 ESTABLISHMENT OF A NEW LARGE ANIMAL MODEL FOR STRESS URINARY INCONTINENCE USING GERMAN LANDRACE PIGS
Anika Albrecht, Alexandra Kelp, Bastian Amend, Tuebingen, Germany; Mario Kluender, Stuttgart, Germany; Arnulf Stenzl, Wilhelm K. Aicher*, Tuebingen, Germany INTRODUCTION AND OBJECTIVES: Stress urinary incontinence (SUI) is a serious problem amongst many women especially after giving child birth. In order to find a better treatment we established a large animal model displaying features of this disease. After evaluation of these animals the long-term goal will be to include this model in different preclinical projects to explore improved or novel methods for SUI diagnosis and therapy.
METHODS: In this study, 9 female German landrace pigs (approx. 20 kg) were included. To induce incontinence group 1 (3 pigs) underwent dilatation of the bladder sphincter for 5 minutes using an 18 Chr balloon catheter filled with 20 ml liquid. Group 2 was treaded with an electro cautery by applying four distinct spots 1 cm from the bladder neck (10 sec, 16 Watt). Group 3 received a combination of dilatation and distal cauterisation (approx. 5 cm from the bladder neck). After 3 weeks standard (s-UPP) and high-definition urethral pressure profilometry (HD-UPP) were performed, the animals were sacrificed and the bladder tissue was harvested for cryo sectioning. AZAN and antibody stainings with reagents to desmin and fast myosin were performed to compare urethra from treated animals with control tissue.
RESULTS: Immediately after treatment animals of all three groups showed a lower s-UPP or HD-UPP compared to the profiles obtained bevor surgical intervention. Only the urethral wall pressure of animals that received dilatation and cauterisation remained reduced after 3 weeks of observation. Animals from group 1 and 2 regenerated just fine and the UPP was even higher than before surgical intervention. AZAN staining and antibody stainings with desmin and fast myosin showed some morphological differences of the muscle tissue in animals of group 3 compared to group 1, 2 and the control. Additionally, signs of electro cautery were clearly visible in group 3.
CONCLUSIONS: The study demonstrated that only dilatation combined with distal cauterisation of the urethra led to incontinent animals, whereas dilatation or proximal cauterisation alone showed no differences in the UPP after 3 weeks of observation. This animal model may represent a good source for further experiments to investigate improved methods for diagnosis or novel therapies for a damaged sphincter muscle.
Source of Funding: none

MP40-10 CAN URETHRAL BULKING AGENTS SALVAGE FAILED SLINGS?
Elizabeth Dray*, Anne Cameron, Marybeth Hall, J. Quentin Clemens, John Stoffel, Ann Arbor, MI INTRODUCTION AND OBJECTIVES: While pubovaginal and midurethral slings are highly effective interventions for stress urinary incontinence (SUI), persistent or recurrent incontinence is not uncommon and can significantly impact patients' quality of life. Multiple studies have shown the relative success of repeat sling procedures in this population, however, not all patients desire further operative interventions. The goal of this study is to evaluate the efficacy of urethral bulking agents for SUI in the setting of failed prior sling which has only been studied in very small populations in the past.
METHODS: This is a retrospective review of patients who underwent urethral bulking agent injections for a primary complaint of e526 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 
